Skip to main content
SpringerLink
Log in

Structural Problems in the Practice of Psychiatric Research

  • Chapter
  • First Online:
Medical Research Ethics: Challenges in the 21st Century

Part of the book series: Philosophy and Medicine ((PHME,volume 132))

  • 448 Accesses

Abstract

This chapter examines various structural and institutional loop-holes and market incentives that allow pharmaceutical companies to maximize profits at the expense of public health, create institutional corruption in academic and healthcare settings, and undermine the scientific integrity of medical research. Practices that are discussed include illegal off-label promotion and prescription of drugs, financial incentives and kick-backs to physicians to alter their prescribing behaviours, financial incentives to academic centres and journals, the deliberate creation and dissemination of biased research findings through ghostwriting, suppression of negative results, and widespread conflicts of interest. The wide-spread systemic nature of these problems means that solutions will have to be equally wide-spread and systemic, with unprecedented changes across multiple sectors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Baker, C.B., M.T. Johnsrud, M.L. Crismon, R.A. Rosenheck, and S.W. Woods. 2003. Quantitative analysis of sponsorship bias in economic studies of antidepressants. The British Journal of Psychiatry 183 (DEC): 498–506.

    Article  Google Scholar 

  • Balon, R., and S. Singh. 2001. Status of research training in psychiatry. Academic Psychiatry 25 (1): 34–41.

    Article  Google Scholar 

  • Bentall, R.P. 1992. A proposal to classify happiness as a psychiatric disorder. Journal of Medical Ethics 18: 94–98.

    Article  Google Scholar 

  • Brown, N., C. A. Vassilas, and C. Oakley. 2009. Recruiting psychiatrists—A Sisyphean task?, Psychiatric Bulletin.

    Google Scholar 

  • Brownlee, J. 2020. The corporate corruption of academic research. Alternate Routes: A Journal of Critical Social Research 26, no. Retrieved from http://alternateroutes.ca/index.php/ar/article/view/22311.

  • Caplan, P.J. 2014. Diagnostisgate: Conflict of interest at the top of the psychiatric aparatus. Aporia Journal 7 (1): 30–41.

    Google Scholar 

  • Chappell, N., A. Cassels, L. Outcalt, and C. Dujela. 2016. Conflict of interest in pharmaceutical policy research: An example from Canada. International Journal of Health Governance 21 (2): 66–75.

    Article  Google Scholar 

  • Christensen, H., P.J. Batterham, I.B. Hickie, P.D. McGorry, P.B. Mitchell, and J. Kulkarni. 2011. Funding for mental health research: The gap remains. Medical Journal of Australia 195 (11): 681–684.

    Article  Google Scholar 

  • Cosgrove, L., and A. Vaswani. 2019. Critical psychiatry. Controversies and Clinical Implications. Springer Nature Switzerland.

    Google Scholar 

  • Cosgrove, L., and E.E. Wheeler. 2013. Drug firms, the codification of diagnostic categories, and bias in clinical guidelines. Journal of Law, Medicine and Ethics 41 (3): 644–653.

    Article  Google Scholar 

  • Cosgrove, L. 2010. Psychiatric taxonomy, psychopharmacology and big pharma. Couns. Sch. Psychol. Fac. Publ. Ser. Pap. 7.

    Google Scholar 

  • Duval, G. 2004. Interest: Protecting accountability. Int Comp Heal Law Ethics A 25-Year Retrosp Winter: 613–626

    Google Scholar 

  • Egilman, D.S., and N.M. Druar. 2011. Corporate versus public interests: Community responsibility to defend scientific integrity. International Journal of Occupational and Environmental Health 17 (2): 181–185.

    Article  Google Scholar 

  • Fanelli, D. 2012. Negative results are disappearing from most disciplines and countries. Scientometrics 90 (3): 891–904.

    Article  Google Scholar 

  • Frances, A.J., and T. Widiger. 2012. Psychiatric diagnosis: Lessons from the DSM-IV past and cautions for the DSM-5 future. Annual Review of Clinical Psychology 8 (1): 109–130.

    Article  Google Scholar 

  • Gagnon, M.A. 2013. Corruption of pharmaceutical markets: Addressing the misalignment of financial incentives and public health. Journal Law, Medicine and Ethics 41 (3): 571–580.

    Article  Google Scholar 

  • Gopal, A.A., L. Cosgrove, and H.J. Bursztajn. 2010. Commentary: The public health consequences of an industry-influenced psychiatric taxonomy: ‘Attenuated Psychotic Symptoms Syndrome’ as a case example. Accountability in Research 17 (5): 264–269.

    Article  Google Scholar 

  • Gøtzsche, P.C., et al. 2009. What should be done to tackle ghostwriting in the medical literature? PLoS Medicine 6 (2): 0122–0125.

    Article  Google Scholar 

  • Hamoda, H.M., M.S. Bauer, D.R. Demaso, K.M. Sanders, and E. Mezzacappa. 2011. A competency-based model for research training during psychiatry residency. Harvard Review of Psychiatry 19 (2): 78–85.

    Article  Google Scholar 

  • Hart, B., A. Lundh, and L. Bero. 2012. Effect of reporting bias on meta-analyses of drug trials: Reanalysis of meta-analyses. BMJ 344 (7838): 1–11.

    Google Scholar 

  • Hughes, S., D. Cohen, and R. Jaggi. 2014. Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: A cross-sectional study. BMJ Open, 4(7).

    Google Scholar 

  • Jablensky, A., R. E. Kendell. 2002. Criteria for assessing a classification in psychiatry. In Psychiatric diagnosis and classification, eds. M. Maj, W. Gaebel, J. J. Lopez-Ibor, and N. Sartorius, 1–24. Wiley.

    Google Scholar 

  • Jernigan, D.B., L. Kargacin, A. Poole, and J. Kobayashi. 2001. Sentinel surveillance as an alternative approach for monitoring antibiotic-resistant invasive pneumococcal disease in Washington State. American Journal of Public Health 91 (1): 142–145.

    Article  Google Scholar 

  • Jureidini, J.N., and L.B. McHenry. 2011. Conflicted medical journals and the failure of trust. Accountability in Research 18 (1): 45–54.

    Article  Google Scholar 

  • Kupfer, D.J., S.E. Hyman, A.F. Schatzberg, H.A. Pincus, and C.F. Reynolds. 2002. Recruiting and retaining future generations of physician scientists in mental health. Archives of General Psychiatry 59 (7): 657–660.

    Article  Google Scholar 

  • Lexchin, J. 2012. Sponsorship bias in clinical research. The International Journal of Risk and Safety in Medicine 24 (4): 233–242.

    Article  Google Scholar 

  • Le Noury, J., et al. 2015. Restoring study 329: Eficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351.

    Google Scholar 

  • McHenry, L.B., and J.N. Jureidini. 2008. Industry-sponsored ghostwriting in clinical trial reporting: A case study. Accountability in Research 15 (3): 152–167.

    Article  Google Scholar 

  • Moffatt, B., and C. Elliott. 2007. Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives in Biology and Medicine 50 (1): 18–31.

    Article  Google Scholar 

  • Polster, C. 2007. The nature and implications of the growing importance of research grants to Canadian universities and academics. Higher Education 53 (5): 599–622.

    Article  Google Scholar 

  • Rafols, I., et al. 2014. Big Pharma, little science?. A bibliometric perspective on Big Pharma’s R&D decline. Technological Forecasting and Social Change 81 (1): 22–38.

    Article  Google Scholar 

  • Rodwin, M.A. 2013. Drug Use. Journal of Law, Medicine and Ethics Fall: 654–664.

    Article  Google Scholar 

  • Rodwin, M.A. 2013. Introduction: Institutional corruption and the pharmaceutical policy. Journal Law, Medicine and Ethics 41 (3): 544–552.

    Article  Google Scholar 

  • Rothman, D.J., et al. 2009. A proposal for controlling conflict of interest. JAMA, the Journal of the American Medical Association 301 (13): 1367–1372.

    Article  Google Scholar 

  • Schafer, A. 2004. Biomedical conflicts of interest: A defence of the sequestration thesis—Learning from the cases of Nancy Olivieri and David Healy. Journal of Medical Ethics 30 (1): 8–24.

    Article  Google Scholar 

  • Schott, G., H. Pachl, U. Limbach, U. Gundert-Remy, W.D. Ludwig, and K. Lieb. 2010. The financing of drug trials by pharmaceutical companies and its consequences. Deutsches Ärzteblatt International 107 (16): 279–285.

    Google Scholar 

  • Sismondo, S. 2009. Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science 39 (2): 171–198.

    Article  Google Scholar 

  • Sismondo, S. 2013. Key opinion leaders and the corruption of medical knowledge: What the sunshine act will and won’t cast light on. Journal Law, Medicine and Ethics 41 (3): 635–643.

    Article  Google Scholar 

  • Smith, R. 2005. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Medicine 2 (5): 0364–0366.

    Article  Google Scholar 

  • Somerville, M.A. 2002. A postmodern moral tale: The ethics of research relationships. Nature Reviews. Drug Discovery 1 (4): 316–320.

    Article  Google Scholar 

  • Stuart, H., et al. 2015. Images of psychiatry and psychiatrists. Acta Psychiatrica Scandinavica 131(1).

    Google Scholar 

  • Turner, E.H. 2013. Publication bias, with a focus on psychiatry: Causes and solutions. CNS Drugs 27 (6): 457–468.

    Article  Google Scholar 

  • van Lent, M., J. Overbeke, and H.J. Out. 2013. Recommendations for a uniform assessment of publication bias related to funding source. BMC Medical Research Methodology 13: 120.

    Article  Google Scholar 

  • Watson, G.L., A.P. Arcona, D.O. Antonuccio, and D. Healy. 2014. Shooting the messenger: The case of ADHD. Journal of Contemporary Psychotherapy 44 (1): 43–52.

    Article  Google Scholar 

  • Yager, J., J. Greden, M. Abrams, and M. Riba. 2004. The institute of medicine’s report on research training in psychiatry residency: Strategies for reform—background, results, and follow up. Academic Psychiatry 28 (4): 267–274.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Queen’s University, Kingston, Canada

    Heather Stuart

Authors
  1. Heather Stuart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heather Stuart .

Editor information

Editors and Affiliations

  1. Charles University, Prague, Czech Republic

    Tomas Zima

  2. International Academy of Law and Mental Health, Montréal, QC, Canada

    David N. Weisstub

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stuart, H. (2023). Structural Problems in the Practice of Psychiatric Research. In: Zima, T., Weisstub, D.N. (eds) Medical Research Ethics: Challenges in the 21st Century. Philosophy and Medicine, vol 132. Springer, Cham. https://doi.org/10.1007/978-3-031-12692-5_24

Download citation

Publish with us

Policies and ethics

Search

Navigation